A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host disease (Q43405471)
Jump to navigation
Jump to search
scientific article published in June 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host disease |
scientific article published in June 2005 |
Statements
1 reference
A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host disease (English)
1 reference
1 reference
Barry Storer
1 reference
Frederick Appelbaum
1 reference
Keith R Jerome
1 reference
Paul Martin
1 reference
Pablo Parker
1 reference
Haydar Frangoul
1 reference
Laura Johnston
1 reference
Paul A Carpenter
1 reference
James Lowder
1 reference
Hanna Khoury
1 reference
Rafat Abonour
1 reference
Peter Westervelt
1 reference
Claudio Anasetti
1 reference
1 June 2005
1 reference
1 reference
11
1 reference
6
1 reference
465-471
1 reference
Identifiers
1 reference
1 reference